Gonadal germ cell tumor

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:363582
Who is this for?
Show terms as
14Active trials47Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Gonadal germ cell tumors are a group of rare cancers that develop from the cells that normally become eggs or sperm. These tumors grow in the ovaries (in females) or the testes (in males). They can occur at any age, from infancy through adulthood, though they are most commonly seen in young adults and adolescents. Germ cell tumors include several subtypes such as seminomas, dysgerminomas, yolk sac tumors, embryonal carcinomas, choriocarcinomas, and teratomas (both mature and immature). Symptoms depend on the location and size of the tumor. In males, a painless lump or swelling in the testicle is the most common sign. In females, symptoms may include abdominal pain, bloating, or a pelvic mass. Some tumors produce hormones that can cause early puberty in children or abnormal bleeding in women. The good news is that many gonadal germ cell tumors respond very well to treatment, especially when caught early. Treatment typically involves surgery to remove the tumor, and depending on the type and stage, chemotherapy may also be needed. Platinum-based chemotherapy regimens, particularly those using cisplatin, have dramatically improved survival rates. Even in cases where the cancer has spread, cure rates remain high for many subtypes, making this one of the more treatable forms of cancer.

Key symptoms:

Painless lump or swelling in the testicleAbdominal pain or bloatingPelvic mass or pressureAbnormal vaginal bleedingEarly puberty in childrenBreast enlargement in malesBack painFeeling of heaviness in the scrotumFatigue and tirednessUnexplained weight lossNausea or vomitingShortness of breath if cancer has spread to lungsIrregular menstrual periodsAbdominal swelling or fluid buildup

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Feb 2026A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

Boehringer Ingelheim — PHASE1

TrialRECRUITING
Jul 2025Sample Collection for Ongoing Research and Product Evaluation Study

Natera, Inc.

TrialRECRUITING
Apr 2024SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours

Imperial College London

TrialNOT YET RECRUITING
Oct 2023A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

LigaChem Biosciences, Inc. — PHASE1, PHASE2

TrialRECRUITING
Nov 2022LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study

University of Alberta

TrialRECRUITING
Jun 2022Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

AstraZeneca — PHASE1, PHASE2

TrialRECRUITING
Jun 2022Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

University Health Network, Toronto

TrialRECRUITING
Dec 2021Radiotherapy vs Observation for Post Chemotherapy Residual Mass in Advanced Seminoma

Tata Memorial Centre — NA

TrialRECRUITING
Sep 2021A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

Memorial Sloan Kettering Cancer Center — NA

TrialRECRUITING
Jan 2021BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

BioInvent International AB — PHASE1, PHASE2

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Gonadal germ cell tumor.

14 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

14 recruitingView all trials with filters →
Phase 31 trial
Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy
Phase 3
Active
PI: Yoshiya Yamada, MD (Memorial Sloan Kettering Cancer Center) · Sites: San Francisco, California; New York, New York +2 more · Age: 1899 yrs
Phase 21 trial
Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma
Phase 2
Actively Recruiting
PI: Yohann LORIOT, MD (Gustave Roussy, Cancer Campus, Grand Paris) · Sites: Villejuif, Val de Marne · Age: 1899 yrs
Phase 12 trials
Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors
Phase 1
Active
· Sites: Toronto, Ontario · Age: 1699 yrs
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
Phase 1
Active
· Sites: Scottsdale, Arizona; Tucson, Arizona +12 more · Age: 1899 yrs
N/A5 trials
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
N/A
Actively Recruiting
PI: Karolina Bryl, PhD (Memorial Sloan Kettering Cancer Center) · Sites: Basking Ridge, New Jersey; Middletown, New Jersey +5 more · Age: 1899 yrs
Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)
N/A
Active
PI: Christine D Berg (National Cancer Institute (NCI)) · Sites: Bethesda, Maryland · Age: 5574 yrs
Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy
N/A
Active
PI: Florence JOLY (Centre François Baclesse) · Sites: Paris, Paris; Angers +17 more · Age: 1899 yrs
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
N/A
Actively Recruiting
PI: Benoit YOU, MD (Hospices Civils de Lyon) · Sites: Bron; Lyon +15 more · Age: 1899 yrs
Radiotherapy vs Observation for Post Chemotherapy Residual Mass in Advanced Seminoma
N/A
Actively Recruiting
· Sites: Mumbai, Maharashtra; Navi Mumbai, Maharashtra · Age: 1880 yrs
Other2 trials
LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
Actively Recruiting
· Sites: Edmonton, Alberta · Age: 1890 yrs
Sample Collection for Ongoing Research and Product Evaluation Study
Actively Recruiting
· Sites: Austin, Texas · Age: 1899 yrs

Specialists

Showing 25 of 47View all specialists →
YM
Yoshiya Yamada, MD
NEW YORK, NY
Specialist
PI on 1 active trial
SP
Stanislaw R. Burzynski, MD, PhD
HOUSTON, TX
Specialist
PI on 29 active trials
JM
James L Gulley, M.D.
BETHESDA, MD
Specialist
PI on 7 active trials
SM
Susan K. Parsons, MD, MRP
Specialist
PI on 1 active trial
PM
Paul Martin
Specialist
PI on 3 active trials73 Gonadal germ cell tumor publications
DP
Dirk J. Grünhagen, MD, PhD
Specialist
PI on 2 active trials
AM
Aude Fléchon, MD
Specialist
PI on 1 active trial1 Gonadal germ cell tumor publication
SP
Suzanne C. Danhauer, PhD
WINSTON SALEM, NC
Specialist
PI on 5 active trials
LM
Lillian Siu, M.D.
Specialist
PI on 2 active trials
RM
Robert DeBernardo, MD
TRUMBULL, CT
Specialist
PI on 1 active trial
MM
Michael Heinrich, MD
Specialist
PI on 1 active trial
JD
Javier Toledo, Medical Degree
Specialist
PI on 1 active trial2 Gonadal germ cell tumor publications
BM
Ben Tran, Medicine
Specialist
PI on 1 active trial1 Gonadal germ cell tumor publication
CP
Carmina Valle, PhD
Specialist
PI on 1 active trial
TG
Thierry Guillaudeux
Specialist
PI on 1 active trial
BD
Barbara Daly
WEYMOUTH, MA
Specialist
PI on 1 active trial
RM
Raymond Muzic
Specialist
PI on 1 active trial
CB
Christine D Berg
Specialist
PI on 1 active trial
KB
Karolina Bryl
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Gonadal germ cell tumor.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Gonadal germ cell tumorForum →

No community posts yet. Be the first to share your experience with Gonadal germ cell tumor.

Start the conversation →

Latest news about Gonadal germ cell tumor

Disease timeline:

New recruiting trial: Sample Collection for Ongoing Research and Product Evaluation Study

A new clinical trial is recruiting patients for Gonadal germ cell tumor

New recruiting trial: Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors

A new clinical trial is recruiting patients for Gonadal germ cell tumor

New recruiting trial: A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

A new clinical trial is recruiting patients for Gonadal germ cell tumor

New recruiting trial: A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

A new clinical trial is recruiting patients for Gonadal germ cell tumor

New recruiting trial: Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

A new clinical trial is recruiting patients for Gonadal germ cell tumor

New recruiting trial: BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

A new clinical trial is recruiting patients for Gonadal germ cell tumor

New recruiting trial: LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study

A new clinical trial is recruiting patients for Gonadal germ cell tumor

New recruiting trial: Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

A new clinical trial is recruiting patients for Gonadal germ cell tumor

New recruiting trial: Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

A new clinical trial is recruiting patients for Gonadal germ cell tumor

New recruiting trial: A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

A new clinical trial is recruiting patients for Gonadal germ cell tumor

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific type of germ cell tumor do I have, and what stage is it?,What are my treatment options, and what are the cure rates for my specific situation?,Should I bank sperm or freeze eggs before starting treatment, and how quickly do we need to act?,What are the short-term and long-term side effects of the recommended treatment?,How often will I need follow-up visits and scans after treatment is complete?,Are there any clinical trials available that might be appropriate for me?,Will I need hormone replacement therapy after treatment?

Common questions about Gonadal germ cell tumor

What is Gonadal germ cell tumor?

Gonadal germ cell tumors are a group of rare cancers that develop from the cells that normally become eggs or sperm. These tumors grow in the ovaries (in females) or the testes (in males). They can occur at any age, from infancy through adulthood, though they are most commonly seen in young adults and adolescents. Germ cell tumors include several subtypes such as seminomas, dysgerminomas, yolk sac tumors, embryonal carcinomas, choriocarcinomas, and teratomas (both mature and immature). Symptoms depend on the location and size of the tumor. In males, a painless lump or swelling in the testicle

How is Gonadal germ cell tumor inherited?

Gonadal germ cell tumor follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Are there clinical trials for Gonadal germ cell tumor?

Yes — 14 recruiting clinical trials are currently listed for Gonadal germ cell tumor on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Gonadal germ cell tumor?

25 specialists and care centers treating Gonadal germ cell tumor are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.